Journal of Pharmacogenomics & Pharmacoproteomics

Stuart A Scott

Stuart A Scott
Assistant Professor, Department of Genetics and Genomic Sciences, Mount Sinai Genetic Testing Laboratory
USA

Biography

Stuart A. Scott, Ph.D., is an Assistant Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and is an ABMGG-certified Associate Director of the Mount Sinai Genetic Testing Laboratory. In the clinical genetics laboratories Dr. Scott is involved in high-complexity molecular testing, including array-based comparative genomic hybridization and exome sequencing. In addition to clinical laboratory diagnostics, his research interests have focused on translational molecular biology, particularly in the areas of pharmacogenomics, cytogenetics and genomics, and epigenomics. Several antiplatelet pharmacogenomics projects are currently ongoing using exome sequencing to identify novel variants implicated in interindividual drug response variability. He has co-authored Clinical Pharmacogenetics Implementation Consortium (CPIC) practice guidelines for pharmacogenetic-guided patient management with warfarin and clopidogrel and is a member of several international pharmacogenomic research consortia, as well as a co-investigator of the eMERGE consortium through Mount Sinai’s Institute for Personalized Medicine (IPM) working on the clinical implementation of pharmacogenomics. Dr. Scott previously was a KL2 Faculty Scholar at Mount Sinai and is now supported by a K23 Translational Scholar Career Award in Phamacogenomics and Personalized Medicine. Other honors include the 2011 William Bowes Jr. Award in Medical Genetics, sponsored by the Center for Personalized Genetic Medicine at Harvard Medical School, and the 2012 Dr. Harold and Golden Lamport Research Award, sponsored by the Icahn School of Medicine at Mount Sinai

Research Interest

Genetics,Genomic Sciences, high-complexity molecular testing, including array-based comparative genomic hybridization, exome sequencing, translational molecular biology, pharmacogenomics, cytogenetics and genomics, and epigenomics, Personalized Medicine